loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of Certificates of Suitability (CEPs) for r1_cep_2013_126___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski PL (1)

filter

01 Risedronate sodium 2.5-hydrate (1)

filter

01 Poland (1)

filter

01 Valid (1)

Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-126 - Rev 02 of Pharmaceutical Works Polpharma S.a. Starogard Gdanski Pl

Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-126 - Rev 02 of Pharmaceutical Works Polpharma S.a. Starogard Gdanski Pl 1

20

Pharmaceutical Works Polpharma S.a. Starogard Gdanski Pl, based in Poland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

One of their significant offerings is Risedronate sodium 2.5-hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-126 - Rev 02

This Chemical Type CEP, issued on May 09, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2572 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY